ストックスクリーナーアプリを入手
0.95
0.55%
0.0052
Evogene Ltd (EVGN) 最新ニュース
Why did EVGN shares drop more than 14% today? - MSN
Evogene Ltd. Expands Google Cloud Collaboration to Integrate AI Agents into ChemPass AI™ - iGrow News
Evogene Secures $3.4 Million Through Warrant Inducement Deal - TipRanks
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases - Finviz
AI-designed drugs take aim at inflammatory diseases affecting millions - Stock Titan
Evogene expands Google Cloud collaboration to enhance AI platform By Investing.com - Investing.com South Africa
Evogene announces warrant inducement deal for $3.4 million By Investing.com - Investing.com Nigeria
Evogene Enters Warrant Inducement Agreement Amid Stock Decline - Intellectia AI
Why Did EVGN Shares Drop More Than 14% Today? - Asianet Newsable
Evogene announces warrant inducement deal for $3.4 million - Investing.com
Evogene raises $3.4M by cutting warrant price to $1 each - Stock Titan
Evogene stock rises as company expands Google Cloud collaboration - Investing.com India
Evogene Ltd. Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI?? - marketscreener.com
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI - Finviz
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™ - PR Newswire
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds - Finviz
Evogene appoints two professors to scientific advisory board By Investing.com - Investing.com South Africa
Evogene Ltd. Appoints Prof. John J. Irwin and Prof. Dan T. Major to Its Scientific Advisory Board - marketscreener.com
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board - Finviz
Evogene appoints two professors to scientific advisory board - Investing.com
Evogene, Shanghai Lishan Sign Exclusive Licensing Deal For Global Development of Microbiome Cancer Drug BMC128 - Voice Of HealthCare
Investment Recap: Is Evogene Ltd. in a consolidation phase2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Evogene and Lishan Biotech Sign Exclusive Licensing Agreement - Intellectia AI
Evogene subsidiary licenses cancer microbiome therapy to Lishan Biotech By Investing.com - Investing.com Nigeria
Evogene (EVGN) Stock: Stabilizes as BMC128 Deal Targets Renal and Lung Cancer Growth - parameter.io
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer - Finviz
Evogene Joins Forces with Unravel Biosciences to Combat Neurological Disorders - StocksToTrade
Evogene Licenses Microbiome-Based Cancer Therapeutic BMC128 To Shanghai Lishan Biopharmaceuticals - Nasdaq
Evogene stock soars after licensing deal for cancer therapeutic By Investing.com - Investing.com Nigeria
Evogene stock soars after licensing deal for cancer therapeutic - Investing.com
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Excl - GuruFocus
Evogene’s Biomica Grants Lishan Biotech Global Rights to Microbiome Cancer Drug BMC128 - TipRanks
Evogene subsidiary licenses cancer microbiome therapy to Lishan Biotech - Investing.com
Earnings Recap: Is Evogene Ltd impacted by rising ratesMarket Growth Report & Capital Protection Trade Alerts - baoquankhu1.vn
Evogene (NASDAQ:EVGN) Shares Cross Below Two Hundred Day Moving Average – What’s Next? - Defense World
Aug Retail: Is Evogene Ltd attractive for institutional investorsJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - baoquankhu1.vn
Jobs Data: How cyclical is SHOTWs revenue stream2025 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
S P Trends: Is McDonalds Corporation stock technically oversoldIndex Update & Reliable Intraday Trade Alerts - baoquankhu1.vn
MACD Signal: Can Evogene Ltd disrupt its industryPortfolio Risk Report & Safe Swing Trade Setups - baoquankhu1.vn
Evogene Announces CFO Resignation and Finance Leadership Transition - TipRanks
Evogene announces CFO resignation and interim appointment By Investing.com - Investing.com Nigeria
Evogene announces CFO resignation and interim appointment - Investing.com
Evogene (NASDAQ: EVGN) plans CFO change as VP Finance steps up to new role - Stock Titan
Evogene Ltd. Announces CFO Changes - marketscreener.com
Breakout Watch: Is Evogene Ltd stock heavily shortedJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
US Market Wrap: How Evogene Ltd stock performs in weak economyNew Guidance & Expert Verified Stock Movement Alerts - Bộ Nội Vụ
Published on: 2026-01-11 04:12:19 - Улправда
Portfolio Shifts: Can Evogene Ltd stock sustain market leadershipDividend Hike & Low Risk Entry Point Guides - moha.gov.vn
HOKA Model Insights: Will Evogene Ltd. stock benefit from upcoming earnings reportsTrail vs Road Selection & updated model highlights and notes - Улправда
Is Evogene Ltd. stock undervalued vs historical averages2025 Buyback Activity & Weekly Watchlist for Hot Stocks - Улправда
Why Evogene Ltd. stock appeals to dividend seekers2025 EndofYear Setup & Real-Time Volume Spike Alerts - Улправда
Is Evogene Ltd. stock attractive for growth ETFsQuarterly Earnings Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Will Evogene Ltd. stock remain a Wall Street favoriteJuly 2025 Reactions & Weekly High Return Opportunities - Улправда
Is Evogene Ltd. stock attractive for hedge fundsWeekly Trade Summary & AI Driven Price Predictions - Улправда
1.00%
1.04%
大文字化:
|
ボリューム (24 時間):